Consistent with our findings and a potential role for ERK5 in various aspects glioma tumour biology, a previous study identified microRNA mediated repression of ERK5 as a possible mechanism to suppress glioma tumour cell growth within in vivo xenograft models through downregulation of epithelial–mesenchymal transition processes [20]. This evidence concerns the gene MAPK7 and central nervous system cancer.